CellaVision AB (CLVSF)
15.85
0.00 (0.00%)
USD |
OTCM |
Feb 20, 16:00
CellaVision Market Cap : 378.05M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Orexo AB | 90.23M |
| BioInvent International AB | 216.40M |
| Hansa Biopharma AB | 290.23M |
| BioArctic AB | 3.368B |
| Camurus AB | 3.459B |
Market Cap Related Metrics
| PE Ratio | 24.23 |
| PS Ratio | 4.880 |
| PEG Ratio | 1.390 |
| Price to Book Value | 3.927 |
| Price to Free Cash Flow | 29.20 |
| Price | 15.85 |
| Earnings Yield | 4.13% |
| PEGY Ratio | 1.271 |
| Operating PE Ratio | 18.38 |
| Normalized PE Ratio | 24.22 |